URS' Ursine Outlook
By Toby Shute
February 29, 2008
I'm afraid that investors have lulled themselves into a false sense of security regarding the various engineering, procurement, and construction (EPC) contractors. Global infrastructure boom? Of course -- no-brainer!
Well, URS (NYSE: URS) shareholders got their security blankets snatched away this week. As with other decoupling theories, the notion that U.S.-exposed EPC folks like Jacobs Engineering (NYSE: JEC) and Chicago Bridge & Iron (NYSE: CBI) are insulated from a housing-led downturn is crumbling. Just like America's infrastructure.
URS management noted "budget shortfalls and deficits facing many state and local governments," which may put a serious damper on infrastructure spending over the next year or two. For example, in the firm's 12 key states, 2008 spending is projected to grow only 3.4%, versus 10.2% last year. California and Florida should be particularly hard-hit, partly because of housing hokum.
Much like Shaw Group (NYSE: SGR), URS will be sheltered to some degree by its serious nuclear-power position. URS doesn't break out its backlog by segment, but this book of business has clearly enjoyed a boost from the firm's recently finalized acquisition of Washington Group. To name but one project, URS is overseeing the construction of a new uranium enrichment facility, which will go toe-to-toe with the American Centrifuge Plant being built by Fluor (NYSE: FLR) for uneasyUSEC (NYSE: USU).
Outside the power sector, URS also counts industrial giants like BHP Billiton (NYSE: BHP) as clients. Finally, there's the federal government, which accounted for more than 40% of revenue in 2007. In short, there are several factors cushioning URS from near-term infrastructure indigestion. That said, past downturns have not been kind to this group, so take care with your EPC investing.
Related Foolishness:
What do the unfolding financial crisis and ongoing market volatility mean for your money? The Fool's here with answers. Get the best of our daily commentary and analysis in your inbox simply by entering your email address in the box below.